X-chromosome-linked immune-deficient mice have B-1b cells

Immunology

Volumn 108, Issue 4, 2003, Pages 440-451

  Riggs, J ^a   Howell, K ^a   Matechin, B ^a   Matlack, R ^a   Pennello, A ^a   Chiasson, R ^a  

^a RIDER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD23 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN M;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMORAL IMMUNITY; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NONHUMAN; PERITONEAL CAVITY; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; X LINKED AGAMMAGLOBULINEMIA;

AGING; ANIMALS; B-LYMPHOCYTE SUBSETS; FEMALE; FLOW CYTOMETRY; GENETIC DISEASES, X-LINKED; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; PERITONEAL CAVITY; SPLEEN;

EID: 0037394595     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01624.x     Document Type: Article

References (51)

1. Scher I. The CBA/N mouse strain: an experimental model illustrating the influence of X chromosome on immunity. Adv Immunol 1982; 33:1-71.
2. Bruton O. Agammaglobulinemia. Pediatrics 1952; 9:722-7.
3. Tsukada S, Saffran D, Rawlings D et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993; 72:279-90.
4. Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinemia (XLA) is a member of the src family of protein-tyrosine kinases. Nature 1993; 361:226-33.
5. Rawlings D, Saffran D, Tsukada S et al. Mutations of a unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993; 261:358-61.
6. Thomas J, Sideras P, Vorechovsky I, Smith C, Chapman V, Paul W. A missense mutation in the X-linked agammaglobulinemia gene colocalizes with the mouse X-linked immunodeficiency gene. Science 1993; 261:355-8.
7. Khan W, Alt F, Gerstein R et al. Defective B cell development and function in Btk-deficient mice. Immunity 1995; 3:283-99.
8. Conley M, Brown P, Pickard A, Buckley R, Miller D, Raskind W, Singer J, Fialkow P. Expression of the gene defect in X linked agammaglobulinemia. N Engl J Med 1986; 315:564-7.
9. Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y, Kadowaki T, Koyasu S. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 1999; 283:390-2.
10. Fruman D, Snapper S, Yballe C, Davidson LYuJ, Alt F, Cantley L. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 1999; 283:393-6.
11. Perlmutter R, Nahm M, Stein K, Slack J, Zitron I, Paul W, Davie J. Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect. J Exp Med 1979; 149:993-8.
12. Amsbaugh D, Hansen C, Prescott B, Stashak P, Barthold D, Baker P. Genetic control of the antibody response to Type III pneumococcal polysaccharides in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J Exp Med 1972; 136:931-6.
13. Scher I, Steinberg A, Berning A, Paul W. X-linked B lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect. J Exp Med 1975; 142:637-50.
14. Hardy R, Hayakawa K, Haaijman J, Herzenberg L. B-cell subpopulations identified by two-color fluorescence analysis using a dual-laser FACS. Nature 1982; 297:589-91.
15. Hayakawa K, Hardy R, Parks D, Herzenberg L. The 'LY-1 B' cell subpopulation in normal, immunodefective, and autoimmune mice. J Exp Med 1983; 157:202-18.
16. Herzenberg L, Stall A, Lalor P, Sidman C, Moore W, Parks D, Herzenberg L. The Ly-1 B cell lineage. Immunol Rev 1986; 93:81-102.
17. Hardy R, Hayakawa K. B cell development pathways. Ann Rev Immunol 2001; 19:595-621.
18. Berland R, Wortis H. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002; 20:253-300.
19. Ochsenbein A, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, Zinkernagel R. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999; 286:2156-9.
20. Macpherson A, Gatto D, Sainsbury E, Harriman G, Hengartner H, Zinkernagel R. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000; 288:2222-6.
21. Baumgarth N, Herman O, Jager G, Brown L, Herzenberg L, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are non-redundant components of the protective response to influenza virus infection. J Exp Med 2000; 192:271-80.
22. Martin F, Oliver A, Kearney J. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001; 14:617-29.
23. Kantor A. A new nomenclature for B cells. Immunol Today 1991; 12:389.
24. Won W-J, Kearney J. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J Immunol 2002; 168:5605-11.
25. Lanier L, Warner N, Ledbetter J, Herzenberg L. Expression of Lyt-1 antigen on certain murine B cell lymphomas. J Exp Med 1981; 153:998-1004.
26. + B cells. Structural and functional characterization in a human chronic lymphocytic leukemia. Eur J Immunol 1988; 18:1131-4.
27. Hinkley K, Chiasson R, Prior T, Riggs J. Age-dependent increase of peritoneal B-1b cells in SCID mice. Immunology 2002; 105:196-203.
28. Howell K, Campo M, Chiasson R, Duffy K, Riggs J. B-1 B cell subset composition of DBA/2J mice. Immunobiology 2002; 205:303-13.
29. Prior L, Pierson S, Woodland R, Riggs J. Rapid restoration of B cell function in XID mice by intravenous transfer of peritoneal cavity B cells. Immunology 1994; 83:180-3.
30. Clarke S, Arnold L. B-1 cell development: evidence for an uncommitted immunoglobulin (Ig) M+ B cell precursor in B-1 cell differentiation. J Exp Med 1998; 187:1325-34.
31. Waldschmidt T, Snapp K, Foy T, Tygrett L, Carpenter C. B-cell subsets defined by the FcεR. Ann NY Acad Sci, 1992; 651:84-90.
32. Unkeless J. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 1979; 150:580-96.
33. Green E and the Staff of The Jackson Laboratory. Biology of the Laboratory Mouse. New York: Dover Publications, 1966.
34. Stall A, Farinas M, Tarlinton D, Lalor P, Herzenberg L, Strober S, Herzenberg L. Ly-1 B cell-clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc Natl Acad Sci USA 1988; 85:7312-6.
35. LeMaoult J, Delassus S, Dyall R, Nikolic-Zugic J, Kourilsky P, Weksler M. Clonal expansions of B lymphocytes in old mice. J Immunol 1997; 159:3866-74.
36. Lam K-P, Rajewsky K. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J Exp Med 1999; 190:471-7.
37. Hayakawa K, Asano M, Shinton S, Gui M, Allman D, Stewart C, Silver J, Hardy R. Positive selection of natural autoreactive B cells. Science 1999; 285:113-6.
38. + B cells both in vivo and in vitro. J Immunol 2000; 164:4586-93.
39. Shaw P, Horkko S, Chang M-K, Curtiss L, Palinski W, Silverman G, Witztum J. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000; 105:1731-40.
40. Wells S, Kantor A, Stall A. CD43 (S7) expression identifies peripheral B cell subsets. J Immunol 1994; 153:5503-15.
41. Rothstein TL. Cutting edge commentary: two B-1 or not to be one. J Immunol 2002; 168:4257-61.
42. Hamilton A, Lehuen A, Kearney J. Immunofluorescence analysis of B-1 cell ontogeny in the mouse. Int Immunol 1994; 6:355-61.
43. Kantor A, Stall A, Adams S, Herzenberg L, Herzenberg L. Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci 1992; 89:3320-4.
44. Wortis H, Teutsch M, Higer M, Zhebg J, Parker D. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc Natl Acad Sci USA 1995; 92:3348-52.
45. Mosier D. Are xid B lymphocytes representative of any normal population? A commentary. J Mol Cell Immunol 1985; 2:70.
46. Hardy R, Hayakawa K, Parks D, Herzenberg L. Demonstration of B-cell maturation in X-linked immunodeficient mice by simultaneous three-colour immunofluorescence. Nature 1983; 306:270-2.
47. Vinuesa C, Sunners Y, Pongracz J, Ball J, Toellner K, Taylor D, MacLennan I, Cook M. Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation. Eur J Immunol 2001; 31:1340-50.
48. Martin F, Kearney J. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 2000; 12:39-49.
49. Ohdan H, Swenson K, Kruger Gray H, Yang Y-G, Xu Y, Thall A, Sykes M. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal1α,3Gal epitopes in α 1,3-galactosyltransferase-deficient mice. J Immunol 2000; 165:5518-29.
50. Woodland R, Schmidt M, Korsmeyer S, Gravel K. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2. J Immunol 1996; 156:2143-54.
51. Chumley M, Dal Porto J, Cambier J. The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen. J Immunol 2002; 169:1735-43.